Cost-Effectiveness Of Pembrolizumab For The First-Line Treatment Of Metastatic Non-Small Cell Lung Carcinoma In Portugal
AuthID
P-00N-CB1
P-00N-CB1
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service